New study checks drug levels in breast milk for moms on YORVIPATH
NCT ID NCT07264634
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 14 times
Summary
This study looks at how much of the drug palopegteriparatide (YORVIPATH) passes into breast milk. It involves 10 lactating women with hypoparathyroidism who are already taking the drug and choose to breastfeed. Researchers will collect milk samples to measure drug levels, helping understand safety for nursing infants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOPARATHYROIDISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ascendis Investigational Site
RECRUITINGMorgantown, West Virginia, 26508, United States
Conditions
Explore the condition pages connected to this study.